Disclosure Panels Details Page
Kidney Cancer Panel - Disclosures as of 04/19/2024
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Date Completed |
|---|---|---|---|---|---|
| Neeraj Agarwal MD | None | None | None | None | 12/24/2023 |
| Ajjai Alva MBBS | Merck & Co., Inc. | None | None | None | 02/14/2024 |
| Hilary Bagshaw MD | None | None | None | None | 02/02/2024 |
| Michael Baine MD,PhD | None | None | None | None | 04/15/2024 |
| Kathryn Beckermann PhD,MD | Aravive Arsenal Biosciences Bristol Myers Squibb Pionyr |
Alpine Aravive Arcus AVEO Pharmaceuticals, Inc. Bristol Myers Squibb Eisai Inc. Exelixis Inc. Merck & Co., Inc. Nimbus Xencor |
None | None | 04/02/2024 |
| Marian Birkeland PhD | None | None | None | None | 04/02/2024 |
| Nicole Blankenhorn | None | None | None | None | 03/04/2024 |
| Maria Carlo MD | None | None | None | None | 04/15/2024 |
| Toni Choueiri MD | AstraZeneca Pharmaceuticals LP AVEO Pharmaceuticals, Inc. Bristol Myers Squibb Eisai Inc. Exelixis Inc. Merck & Co., Inc. Pfizer Inc. |
Arcus Bio Bristol Myers Squibb Eisai Inc. Gilead Sciences, Inc. Merck & Co., Inc. Nuscan Tempest |
None | ASCO (non-profit, starts 6/2024 for 4 years)|Filed patents regarding response and toxicity to immunotherapy and ctDNA/liquid biopsies. No income | 03/01/2024 |
| Brian Costello MS,MD | None | None | None | None | 04/19/2024 |
| Ithaar Derweesh MD | Pfizer Inc. | None | None | None | 04/21/2023 |
| Arpita Desai MD | Exelixis Inc. Merck & Co., Inc. |
AVEO Pharmaceuticals, Inc. Dendreon Corporation Exelixis Inc. Janssen Pharmaceutica Products, LP Merck & Co., Inc. |
None | None | 04/17/2024 |
| Tanya Fischer MLIS,MEd | None | None | None | None | 12/06/2023 |
| Yasser Ged MBBS | None | Eisai Inc. Exelixis Inc. |
None | None | 10/05/2023 |
| Saby George MD,FACP | AVEO Pharmaceuticals, Inc. Bayer HealthCare Bristol Myers Squibb Eisai Inc. Exelixis Inc. Gilead Sciences, Inc. Merck & Co., Inc. Novartis Pharmaceuticals Corporation |
AstraZeneca Pharmaceuticals LP Bayer HealthCare Bristol Myers Squibb Eisai Inc. Merck & Co., Inc. Novartis Pharmaceuticals Corporation |
None | None | 12/21/2023 |
| John Gore MS,MD | None | Immunity Bio | None | None | 02/28/2024 |
| Kristina Gregory MSN,RN | None | None | None | None | 01/10/2024 |
| Andrew Gunn MD | Boston Scientific Corporation Penumbra, Inc Varian Medical Systems, Inc. |
BTG Penumbra Varian Medical Systems, Inc. |
None | None | 04/01/2024 |
| Lisa Gurski PhD | None | None | None | None | 04/17/2024 |
| Naomi Haas MD | Sidney Kimmel Cancer Center | Eisai Inc. Merck & Co., Inc. |
None | None | 04/16/2024 |
| Evelyn Handel PharmD,BCPS,BCOP | None | None | None | None | 02/02/2024 |
| Erin Hesler | None | None | None | None | 12/22/2023 |
| Anne Holbrook PharmD,BCOP | None | None | None | None | 12/04/2023 |
| Michael Johnson MD | None | Janssen Pharmaceutica Products, LP | Janssen Pharmaceutica Products, LP Merck & Co., Inc. |
None | 03/23/2024 |
| Eric Jonasch MD | Arrowhead AVEO Pharmaceuticals, Inc. Corvus Merck & Co., Inc. NiKang Novartis Pharmaceuticals Corporation ProFoundBio Takeda Pharmaceuticals North America, Inc. Telix |
AVEO Pharmaceuticals, Inc. Eisai Inc. Exelixis Inc. Ipsen Merck & Co., Inc. NiKang Novartis Pharmaceuticals Corporation |
None | None | 02/14/2024 |
| Payal Kapur MD | None | ClearNano Inc | None | None | 12/26/2023 |
| Jennifer King MD | None | None | None | None | 11/22/2023 |
| Christos Kyriakopoulos MD | AstraZeneca Pharmaceuticals LP Bristol Myers Squibb Gilead Sciences, Inc. Immunomedics, Inc. Incyte Corporation Madison Vaccines, Inc. Merck & Co., Inc. Pionyr Immunopharma sanofi-aventis U.S. |
None | None | None | 11/24/2023 |
| Elaine Lam MD | Amgen Inc. Arrowhead Astellas Pharma US, Inc. Biosplice Bristol Myers Squibb Exelixis Inc. Flatiron Health, Inc. Forma Therapeutics Genentech, Inc. Harpoon Therapeutics HiberCell Merck & Co., Inc. Peloton Therapeutics, Inc. Pfizer Inc. Promontory Therapeutics (formerly Phosplatin) Roche Laboratories, Inc. |
Pathos | None | None | 12/31/2023 |
| Primo Lara, Jr. MD | AstraZeneca Pharmaceuticals LP | None | None | None | 04/17/2024 |
| Clayton Lau MD | None | None | Medtronic, Inc. | None | 04/17/2024 |
| Bryan Lewis JD | None | None | None | None | 08/29/2023 |
| David Madoff MD | Merck & Co., Inc. Sirtex |
Boston Scientific Corporation CAPS Medical General Electric Johnson & Johnson Merck & Co., Inc. Microbot Medical Quantum Surgical Siemens Medical Solutions Diagnostics Sirtex |
None | None | 01/27/2024 |
| Brandon Manley MD | None | None | None | None | 04/16/2024 |
| M. Dror Michaelson PhD,MD | None | Janssen Pharmaceutica Products, LP Merck & Co., Inc. |
None | None | 03/17/2024 |
| Amir Mortazavi MD | Acerta Pharma Astellas Pharma US, Inc. Bristol Myers Squibb Debiopharm Group Genentech, Inc. GSK Merck & Co., Inc. Mirati Therapeutics Novartis Pharmaceuticals Corporation Roche Laboratories, Inc. SeaGen |
None | Targeted Oncology | None | 02/05/2024 |
| Robert Motzer MD | AVEO Pharmaceuticals, Inc. Bristol Myers Squibb Eisai Inc. Exelixis Inc. Merck & Co., Inc. Pfizer Inc. |
Merck & Co., Inc. Takeda Pharmaceuticals North America, Inc. |
None | None | 01/12/2024 |
| Lee Ponsky MD | None | LeVee Medical Inc | None | None | 04/17/2024 |
| Donna Powell CMD,DHSc,RT(T) | None | None | None | None | 03/13/2024 |
| Sundhar Ramalingam MD | None | None | None | None | 04/18/2024 |
| Ryan Schonfeld BA | None | None | None | None | 02/05/2024 |
| Brian Shuch MD | None | Johnson & Johnson Merck & Co., Inc. Telix Veracyte |
None | None | 04/18/2024 |
| Jeffrey Sosman MD | None | Jazz Pharmaceuticals Inc. Pfizer Inc. |
None | None | 03/24/2023 |
| MaryElizabeth Stein PhD | None | None | None | None | 04/17/2024 |
| Bettyanne Sunderland OCN,BSN | None | None | None | None | 12/12/2023 |
| Randy Sweis MD | Ascendis Astellas Pharma US, Inc. Bayer Bristol Myers Squibb Gilead Sciences, Inc. Immunocore Loxo-Lilly Merck & Co., Inc. Mirati Moderna Pionyr Pyxis Oncology Scholar Rock |
AstraZeneca Pharmaceuticals LP AVEO Pharmaceuticals, Inc. Eisai Inc. Exelixis Inc. |
None | AbbVie, Inc.|Patent: Neoantigens in Cancer, PCT/US2020/031357 | 04/19/2024 |
| Matthew Zibelman MD | Bristol Myers Squibb Exelixis Inc. Replimmune |
AVEO Pharmaceuticals, Inc. Blue Earth Diagnostics Exelixis Inc. Janssen Pharmaceutica Products, LP Merck & Co., Inc. |
None | None | 03/11/2024 |